Dietary, pharmacologic and surgical treatment of hyperlipidemia were included as interventions. The effect of lipid intervention on the overall mortality were analyzed and data that allowed calculation of gender-specific mortality rates were included. The primary outcomes were the overall mortality for all...
Treatment of hyperlipidemia in women.Assesses the evidence that lipid lowering prevents coronary heart disease events in women. Review of literature on the effects of cholesterol lowering with dietary and drug interventions; Examination of the coronary heart disease and total mortality outcomes.Walsh...
Walsh JM, Pignone M. Drug treatment of hyperlipidemia in women. JAMA. 2004; 291:2243-2252.Walsh JM, Pignone M. Drug treatment of hyperlipidemia in women. JAMA 2004;291:2243-52.Walsh, J.M. Pignone, M. Drug Treatment of hyperlipidemia in women. Journal of the American Medical Asso- ...
Drug treatment of hyperlipidemia in women This review looked for evidence on the use of drugs to reduce hyperlipidaemia in women. The authors found that for women without cardiovascular disease (CV... pmhdev 被引量: 316发表: 2004年 Recommendations for treatment of hyperlipidemia in adults. A joi...
Absolute mortality in each category is also displayed. Mortality figures were not adjusted for other confounding variables (hypertension, diabetes, tobacco use, or hyperlipidemia). Figure 2. View LargeDownload Odds ratios and 95% confidence intervals for mortality effects for the variables listed. IV ...
Several of the more effective methods of treating hyperlipidemia were discovered by accident. In some cases the mode of action of the agents remains unknown. As long as this state of ignorance persists, one must harbor some misgivings that, despite a satisfying fall in blood lipid concentrations,...
Screening for hyperlipidemia should begin no later than age 35 for men and age 45 for women. Individuals with additional risk factors for coronary artery disease should be screened earlier. When values are not within a desirable range, further assessment should be done by determining high-density ...
causes of hyperlipidemia (e.g., the nephrotic syndrome), the use of lipid-lowering drugs in women, and recommendations for drug therapy in older ... M. Lytken Larsen MD,D. Roger Illingworth MD, PhD - 《Medical Clinics of North America》 被引量: 136发表: 1994年 Sugars and starch in ...
Recent data indicate that high serum cholesterol and low-density lipoprotein levels remain a risk factor for coronary heart disease (CHD) in patients over 60 years of age. Of all age groups, men and women over this age have the highest prevalence of CHD. Although the importance of the reduct...
Additionally, clinical studies evaluating the impact of lipid-lowering therapy in a larger number of women, the elderly (> 70 y), and patients with diabetes for treatment of primary and secondary prevention of coronary heart disease are needed. 展开 关键词: atorvastatin hypercholesterolemia ...